双水平正压通气联合雾化吸入治疗老年AECOPD合并Ⅱ型呼吸衰竭的临床对照研究  

The Clinical effi cacy of BiPAP Machine in the Treatment of AECOPD with Type Ⅱ Respiratory Failure

作　　者：胡涛[1] 

机构地区：[1]四川省人民医院呼吸科,四川成都610017

出　　处：《现代仪器与医疗》2015年第2期53-55,共3页Modern Instruments & Medical Treatment

摘　　要：目的 :考察双水平正压通气联合雾化吸入治疗老年AECOPD合并Ⅱ型呼吸衰竭临床效果。方法 :将76例AECOPD合并II型呼吸衰竭患者随机分为观察组与对照组各38例,对照组给予常规治疗,观察组在对照组基础上加行双水平正压通气与特普他林、布地奈德雾化吸入联合治疗方案。结果:治疗后观察组患者RR与RH等临床症状以及血p H、Pa CO2、Pa O2等血气指标改善效果均显著优于对照组(P<0.05),同时观察组平均住院时间与总体医疗费用支出也均显著少于对照组(P<0.05)。结论:双水平正压通气联合雾化吸入治疗老年AECOPD合并Ⅱ型呼吸衰竭临床疗效确切,费用相对更低,建议将其作为当前治疗老年AECOPD首选方案应用。Objective： To investigate the bi-level positive airway pressure ventilation combined inhalation therapy in elderly AECOPD with type Ⅱ respiratory failure clinical results. Methods： 76 patients with AECOPD joint type II respiratory failure were randomly divided into observation group and control group, 38 cases in the control group received conventional treatment, observation group Bi-PAP line with terbutaline and budesonide in the control group on the basis of combination therapy of budesonide inhalation. Results： After treatment, the clinical symptoms observed in patients with RR-RH and improving effectiveness of blood p H, Pa CO2, Pa O2 and other blood indicators were significantly better than the control group（P〈0.05）, while observing the group, the average length of stay and overall medical expenses were also significantly less than the control group（P〈0.05）. Conclusions： Bi-PAP combined inhalation therapy in elderly AECOPD with type Ⅱ respiratory failure clinical efficacy, relatively lower costs, recommended as the current treatment of choice for elderly AECOPD program application.

关 键 词：AECOPD 老年 双水平正压通气 雾化吸入 

分 类 号：R563.5[医药卫生—呼吸系统]